Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions.

Marrer É, Jolly D, Arveux P, Lejeune C, Woronoff-Lemsi MC, Jégu J, Guillemin F, Velten M.

BMC Cancer. 2017 Jan 11;17(1):47. doi: 10.1186/s12885-016-3029-z.

2.

Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC.

Curr Oncol. 2016 Jun;23(3):e179-87. doi: 10.3747/co.23.2988.

3.

Pulmonary nodules and CT screening: the past, present and future.

Ruparel M, Quaife SL, Navani N, Wardle J, Janes SM, Baldwin DR.

Thorax. 2016 Apr;71(4):367-75. doi: 10.1136/thoraxjnl-2015-208107. Review.

4.

Demonstration program of population-based lung cancer screening in China: Rationale and study design.

Zhou Q, Fan Y, Wu N, Huang Y, Wang Y, Li L, Liu J, Wang X, Li W, Qiao Y.

Thorac Cancer. 2014 May;5(3):197-203. doi: 10.1111/1759-7714.12078.

5.

China national lung cancer screening guideline with low-dose computed tomography (2015 version).

Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, Wang G, Wang XY, Qiao YL.

Thorac Cancer. 2015 Nov;6(6):812-8. doi: 10.1111/1759-7714.12287.

6.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice..

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

7.

Screening tests: a review with examples.

Maxim LD, Niebo R, Utell MJ.

Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Review.

8.
9.

Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.

Rzyman W, Jelitto-Gorska M, Dziedzic R, Biadacz I, Ksiazek J, Chwirot P, Marjanski T.

Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):969-73. doi: 10.1093/icvts/ivt388.

10.

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB.

Chest. 2013 May;143(5 Suppl):e78S-92S. doi: 10.1378/chest.12-2350. Review.

11.

American Cancer Society lung cancer screening guidelines.

Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA.

CA Cancer J Clin. 2013 Mar-Apr;63(2):107-17. doi: 10.3322/caac.21172. Review.

12.

Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Barry SA, Tammemagi MC, Penek S, Kassan EC, Dorfman CS, Riley TL, Commin J, Taylor KL.

J Natl Cancer Inst. 2012 Nov 7;104(21):1647-59. doi: 10.1093/jnci/djs398.

13.

Benefits and harms of CT screening for lung cancer: a systematic review.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521. Review. Erratum in: JAMA. 2013 Jun 5;309(21):2212. JAMA. 2012 Oct 3;308(13):1324.

14.

Lung cancer screening.

Pastorino U.

Br J Cancer. 2010 Jun 8;102(12):1681-6. doi: 10.1038/sj.bjc.6605660. Review.

15.

Smoking behavior 1 year after computed tomography screening for lung cancer: Effect of physician referral for abnormal CT findings.

Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3484-9. doi: 10.1158/1055-9965.EPI-09-0895.

16.

Clinical impact of high-throughput gene expression studies in lung cancer.

Beane J, Spira A, Lenburg ME.

J Thorac Oncol. 2009 Jan;4(1):109-18. doi: 10.1097/JTO.0b013e31819151f8. Review.

17.

Radiation risk of screening with low dose CT.

Karadi RL.

Thorax. 2006 Jun;61(6):548. No abstract available.

18.

Is screening for lung cancer using low dose spiral CT scanning worthwhile?

Gleeson FV.

Thorax. 2006 Jan;61(1):5-7. No abstract available.

Items per page

Supplemental Content

Support Center